Patient-derived ex vivo models to test drug responses of disseminated cancer cells in various metastatic niches

被引：0
|
作者：
Wohrl, Lukas
Botteron, Catherine
Weidele, Kathrin
Treitschke, Steffi
Das, Durdam
Werner-Klein, Melanie
Hoffmann, Martin
Guzvic, Natasa Stojanovic
Materna-Reichelt, Silvia
Weber, Florian
Engelmann, Simon
Mayr, Roman
Guzvic, Miodrag
Haferkamp, Sebastian
Seitz, Stephan
Klein, Christoph A.
Werno, Christian
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4124
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PATIENT-DERIVED CELLS FOR EX VIVO DRUG SCREENING STUDIES OF GLIOMAS
    El-Heliebi, Amin
    Urbanic-Purkart, Tadeja
    Mahdy-Ali, Kariem
    Skofler, Christina
    Gerlitz, Lisa
    Stanzer, Stefanie
    Franz, Joakim
    Harbusch, Nora
    Madl, Tobias
    Widhalm, Georg
    Rossler, Karl
    Tomberger, Martina
    Mattersdorfer, Karin
    Kroneis, Thomas
    Oberhuber, Monika
    Pieber, Thomas
    Prietl, Barbara
    NEURO-ONCOLOGY, 2022, 24 : 209 - 209
  • [2] Three-Dimensional Ex Vivo Culture for Drug Responses of Patient-Derived Gastric Cancer Tissue
    Chen, Sian
    Chen, Chenbin
    Hu, Yuanbo
    Zhu, Ce
    Luo, Xiaozhi
    Wang, Lizhu
    Wang, Xiang
    Sun, Xiangwei
    Chen, Xiaodong
    Xie, Wangkai
    Lou, Han
    Huang, Xielin
    Li, Chao
    Xu, Jun
    Xue, Xiangyang
    Shen, Xian
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [3] DEVELOPMENT OF AN EX-VIVO PATIENT-DERIVED EXPLANT MODEL FOR PREDICTING DRUG RESPONSES IN ENDOMETRIAL CANCER
    Collins, A.
    Miles, G.
    MacFarlane, M.
    Pritchard, C.
    Moss, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A162 - A162
  • [4] Development of preclinical in vitro/in vivo models from patient-derived disseminated tumor cells
    Botteron, Catherine
    Werno, Christian
    Weidele, Kathrin
    Treitschke, Steffi
    Scheitler, Sebastian
    Polzer, Bernhard
    Werner-Klein, Melanie
    Klein, Christoph Andreas
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (08) : 496 - 496
  • [5] Evaluation of patient-derived cell lines and cancer organoids for the prediction of drug responses in patient-derived xenograft models
    Campbell, Petreena
    Hose, Curtis
    El Touny, Lara
    Harris, Erik
    Connelly, John
    Bonomi, Carrie
    Dougherty, Kelly
    Styers, Savanna
    Walke, Abigail
    Moyer, Jenna
    Baldwin, Mariah
    Wade, Anna
    Mullendore, Michael
    Arthur, Kaitlyn
    Murphy, Matthew
    Plater, Kevin
    Gibson, Marion
    Geraghty, Joseph
    Gottholm-Ahalt, Michelle
    Grinnage-Pulley, Tara
    Chase, Tiffanie
    Carter, John
    Stotler, Howard
    Trail, Debbie
    Stockwin, Luke
    Newton, Dianne
    Evrard, Yvonne
    Hollingshead, Melinda
    Parchment, Ralph E.
    Coussens, Nathan P.
    Teicher, Beverly A.
    Doroshow, James H.
    Rapisarda, Annamaria
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Prognostic Utility of the Patient-Derived AML Cells' Ex Vivo Drug Sensitivity Results
    Park, Silvia
    Park, Sung-Soo
    Cho, Byoung Sik
    Lim, Sungwon
    Kim, Kwan Hyun
    Choi, Gyucheol
    Ham, Seunghyeok
    Lee, Seongjoon
    Park, Sesun
    Lee, Gunjae
    Lee, Junyoung
    Song, Edward
    Koo, Jamin
    Kim, Heeje
    BLOOD, 2023, 142
  • [7] Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
    Pettersen, Solveig
    oy, Geir Frode
    Egeland, Eivind Valen
    Juell, Siri
    Engebraten, Olav
    Maelandsmo, Gunhild Mari
    Prasmickaite, Lina
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells
    Saeed, Khalid
    Ojamies, Poojitha
    Pellinen, Teijo
    Eldfors, Samuli
    Turkki, Riku
    Lundin, Johan
    Jarvinen, Petrus
    Nisen, Harry
    Taari, Kimmo
    af Hallstrom, Taija M.
    Rannikko, Antti
    Mirtti, Tuomas
    Kallioniemi, Olli
    Ostling, Paivi
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (06) : 1356 - 1366
  • [9] Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
    Hou, Xiaoying
    Du, Cong
    Lu, Ligong
    Yuan, Shengtao
    Zhan, Meixiao
    You, Pengtao
    Du, Hongzhi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [10] Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
    Xiaoying Hou
    Cong Du
    Ligong Lu
    Shengtao Yuan
    Meixiao Zhan
    Pengtao You
    Hongzhi Du
    World Journal of Surgical Oncology, 20
12345